Ulcerative Colitis Uc clinical trials

Explore recruiting ulcerative colitis uc clinical trials.

Recruiting ulcerative colitis uc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ulcerative Colitis Uc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, Multicenter Induction Study with an Active Treatment Extension to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Patients with Moderate to Severe Ulcerative Colitis

Belgium, Germany, France, Italy, Czechia, Greece +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

T-FORE - Pilot study of a new technique of Oral Fecal Transplantation using frozen stool capsules for the maintenance treatment of pediatric Ulcerative Colitis (UC)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

Austria, Poland, Croatia, Netherlands, Germany, Greece +12 more

Therapeutic exploratory (Phase II) EU CTIS Study details

VERDICT: In actiVE ulcerative colitis, a RanDomIzed Controlled Trial for determination of the optimal treatment target

Italy, Belgium, France, Netherlands, Poland

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study Evaluating the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Spain, Romania, France, Italy, Czechia, Poland +4 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 Long-Term Extension (LTE) Study to Evaluate The Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis

Austria, Denmark, Finland, Slovakia, Italy, Romania +11 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Ulcerative Colitis Uc trials by city

Ulcerative Colitis Uc in Toronto Ulcerative Colitis Uc in Vancouver Ulcerative Colitis Uc in Montreal Ulcerative Colitis Uc in Calgary Ulcerative Colitis Uc in Edmonton Ulcerative Colitis Uc in Ottawa Ulcerative Colitis Uc in Winnipeg Ulcerative Colitis Uc in Quebec City Ulcerative Colitis Uc in Hamilton Ulcerative Colitis Uc in Kitchener Ulcerative Colitis Uc in London Ulcerative Colitis Uc in Halifax Ulcerative Colitis Uc in New York Ulcerative Colitis Uc in Los Angeles Ulcerative Colitis Uc in Chicago Ulcerative Colitis Uc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease